Rathbones Group PLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,447 shares of the company’s stock after selling 2,324 shares during the quarter. Rathbones Group PLC’s holdings in HCA Healthcare were worth $17,721,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare in the fourth quarter worth approximately $31,000. Cedar Mountain Advisors LLC acquired a new position in shares of HCA Healthcare during the 1st quarter valued at $33,000. JPL Wealth Management LLC bought a new position in HCA Healthcare during the third quarter valued at about $33,000. Finally, MCF Advisors LLC raised its position in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.
HCA Healthcare Trading Up 0.9%
NYSE:HCA opened at $406.07 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm has a market capitalization of $87.92 billion, a price-to-earnings ratio of 13.59, a PEG ratio of 1.40 and a beta of 1.12. The business’s fifty day moving average price is $387.29 and its 200 day moving average price is $450.48.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.45%.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on HCA. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Mizuho decreased their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 28th. Oppenheimer reduced their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. JPMorgan Chase & Co. reduced their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Finally, Cantor Fitzgerald dropped their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $465.59.
Get Our Latest Analysis on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
